Therapeutic Evaluation of Unani Pharmacopoeial Formulation in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)- A Single Blind RandomisedPlacebo Controlled Study - NI

Department of Moalejat, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年9月18日

试验速览

暂无简介。

•1.Patient of either gender
•2.Age between 20-60 years
•3.Non alcoholic
•4.BMI = 35 kg/M2
•5.Diagnosed case of fatty liver by ultrasound (Upto Grade II)
•6.Asymptomatic and symptomatic (anorexia, nausea, dyspepsia, and right hypochondrial discomfort)
•7.Patient is able to participate in study and ready to follow the instructions and sign the informed consent form.

•1.Age < 20 years or > 60 years.
•2.BMI >35kg/M2.
•3.Positive hepatitis marker.
•4.Patients suffering from cardiopulmonary, renaldisease, malignancy and uncontrolled type 2 diabetes mellitus.
•5.Patients with severe deranged lipid profile and liver function test.
•6.Patients receiving treatment with drugs such as oestrogens, corticosteroids, sodium valproate, tamoxifen and statins.
•7.Pregnant and lactating women.
•8.Non-compliant patients.
•9.Patients failed to follow up.

发起方

Department of Moalejat, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh